Definium Therapeutics Inc (DFTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -108,679 | -73,938 | -60,254 | -54,400 | -95,732 |
| Depreciation Amortization | 527 | 527 | 527 | 527 | 3,263 |
| Accounts payable and accrued liabilities | -2,126 | -1,987 | -1,453 | 1,509 | 2,025 |
| Other Working Capital | -3,344 | -3,119 | -4,127 | -677 | 6,281 |
| Other Operating Activity | 34,493 | 24,739 | 28,720 | 36,443 | 19,798 |
| Operating Cash Flow | $-79,129 | $-53,778 | $-36,587 | $-16,598 | $-64,365 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 10,000 | 10,000 | 10,000 | N/A | 15,000 |
| Common Stock Issued | 258,983 | 256,085 | 180,070 | 178,149 | 163 |
| Other Financing Activity | -15,787 | -16,696 | -10,035 | -8,902 | 6,685 |
| Financing Cash Flow | $253,196 | $249,389 | $180,035 | $169,247 | $21,848 |
| Exchange Rate Effect | -30 | -31 | -20 | -21 | 79 |
| Beginning Cash Position | 99,704 | 99,704 | 99,704 | 99,704 | 142,142 |
| End Cash Position | 273,741 | 295,284 | 243,132 | 252,332 | 99,704 |
| Net Cash Flow | $174,037 | $195,580 | $143,428 | $152,628 | $-42,438 |
| Free Cash Flow | |||||
| Operating Cash Flow | -79,129 | -53,778 | -36,587 | -16,598 | -64,365 |
| Free Cash Flow | -79,129 | -53,778 | -36,587 | -16,598 | -64,365 |